Regeneron gets emergency US clearance for Covid-19 therapy

The treatment, administered to President Donald Trump after he contracted the coronavirus in October, consists of two monoclonal antibodies that target the spike protein used by the virus to enter cells. Trump was treated with the drug based on a compassionate-use request by his doctors.

from Hindustan Times - world https://bit.ly/2ITiuCt
https://ift.tt/2zbki14